Phantom Neuro Launches First-in-Human Trial for Prosthetic Control System

Phantom Neuro has received approval to begin its first-in-human trial of the Phantom X system, a minimally invasive muscle-machine interface designed to improve prosthetic control.

The early feasibility study, CYBORG, will enroll up to ten below-the-elbow amputees in Melbourne, with procedures conducted at Cabrini Health. The trial will evaluate the system’s safety, usability, and ability to enable real-time control of prosthetic devices.

Participants will undergo a single outpatient implant procedure, followed by recovery and fitting with a compatible prosthetic. They will then be monitored over a 20-week period.

The Phantom X system uses implantable sensors placed in the residual limb to capture muscle signals and translate them into precise movements. Unlike more invasive brain or nerve interfaces, it avoids direct interaction with the nervous system, offering a potentially safer and more intuitive solution for prosthetic control.

The study marks a key step toward broader clinical development and future commercialization.

20-04-2026